Galmed Pharmaceuticals Ltd expected to post a loss of 10 cents a share - Earnings Preview

Eocene

12/05/2023 15:22

* Galmed Pharmaceuticals Ltd  GLMD.OQ   GLMD.O  is expected
to report  results on May 15 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Galmed
Pharmaceuticals
Ltd is for a loss of 10 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts had risen by
about 6.7%
in the last three months. ​

This summary was machine generated May 12 at 14:22 GMT.  All
figures in US dollars  unless otherwise stated